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Mesenchymal stromal cells (MSCs) constitute the cell type more frequently used in many
regenerative medicine approaches due to their exclusive immunomodulatory properties,
and they have been reported to mediate profound immunomodulatory effects in vivo.
Nevertheless, MSCs do not express essential adhesion molecules actively involved
in cell migration, a phenotypic feature that hampers their ability to home inflamed
tissues following intravenous administration. In this study, we investigated whether
modification by fucosylation of murine AdMSCs (mAdMSCs) creates Hematopoietic Cell
E-/L-selectin Ligand, the E-selectin-binding CD44 glycoform. This cell surface glycan
modification of CD44 has previously shown in preclinical studies to favor trafficking
of mAdMSCs to inflamed or injured peripheral tissues. We analyzed the impact that
exofucosylation could have in other innate phenotypic and functional properties of
MSCs. Compared to unmodified counterparts, fucosylated mAdMSCs demonstrated
higher in vitro migration, an altered secretome pattern, including increased expression
and secretion of anti-inflammatory molecules, and a higher capacity to inhibit mitogen-
stimulated splenocyte proliferation under standard culture conditions. Together, these
findings indicate that exofucosylation could represent a suitable cell engineering strategy,
not only to facilitate the in vivo MSC colonization of damaged tissues after systemic
administration, but also to convert MSCs in a more potent immunomodulatory/anti-
inflammatory cell therapy-based product for the treatment of a variety of autoimmune,
inflammatory, and degenerative diseases.
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INTRODUCTION
Mesenchymal stromal cells (MSCs) are a heterogeneous multipotent progenitor cell population
found in almost all adult tissues throughout the body. MSCs possess the ability of self-renewal and
mesodermal lineage differentiation (e.g., osteocytes, adipocytes, and chondrocytes), and mediate
tissue repair through the production of different molecules with trophic actions (Caplan, 2007;
Chamberlain et al., 2007). Remarkably, MSCs also exhibit unique anti-inflammatory and
immunoregulatory properties by the secretion of non-conclusively determined anti-inflammatory
Frontiers in Cell and Developmental Biology | www.frontiersin.org 1 November 2020 | Volume 8 | Article 584074
fcell-08-584074 November 21, 2020 Time: 13:28 # 2
García-Bernal et al. Exofucosylation Alters MSC Secretome
molecules, including IL10, TGFβ, heme-oxygenase, IDO1, PGE2,
HGF, galectin-1, and direct cell-to-cell contacts (Krampera
et al., 2003; Yañez et al., 2010; Najar et al., 2016). Because
of all these intrinsic features, MSCs have been considered
a promising cell therapy product for a variety of systemic
inflammatory disorders, including rheumatoid arthritis, graft-
versus-host disease, multiple sclerosis, or type 1 diabetes (Lee
et al., 2006; Yañez et al., 2006; Augello et al., 2007; Gerdoni et al.,
2007; Abdi et al., 2015).
An important issue for adoptive cellular therapeutics is that
the MSC immunomodulatory effectiveness is closely related to
the ability of the systemically administered cells to traffic and
infiltrate the inflamed tissues (Lee et al., 2006; Abdi et al., 2015). In
mammals, microvascular endothelial beds at injured or inflamed
tissues express E-selectin, whose expression is up-regulated by
pro-inflammatory cytokines such as IL-1 and TNFα (Sackstein,
2009; Thankamony and Sackstein, 2011). E-selectin is a Ca2+-
dependent endothelial lectin belonging to “selectins” family
that prototypically bind sialofucosylated glycan determinants
expressed on their respective ligands (i.e., glycoproteins and/or
glycolipids), specifically the terminal tetrasaccharide motif sialyl
Lewis X (sLex). However, MSCs lack expression of ligands for
E-selectin, such as sialofucosylated PSGL-1, CD43, and CD44
glycoforms, molecules called cutaneous lymphocyte antigen
(CLA), CD43E, and Hematopoietic Cell E-/L-selectin Ligand
(HCELL), respectively, Sackstein et al. (2008). The absence
of these molecular effectors of cell migration hinders the
capacity of infused MSCs to extravasate into the inflamed tissues
following systemic administration (Kang et al., 2012; Eggenhofer
et al., 2014; Abdi et al., 2015), limiting the efficacy of this
immunomodulatory cell therapy. Therefore, it is important to
design new cell engineering based-strategies for improving the
tissue delivery of MSCs to inflamed tissues.
Mammalian MSCs characteristically express CD44, and
stereospecific CD44 glycoengineering via fucosyltransferase-
mediated fucose modification of N-acetylglucosamine results in
the transient generation of the tetrasaccharide sLex (Sackstein
et al., 2008; Abdi et al., 2015; Lopez-Lucas et al., 2018).
Exofucosylation of CD44 on MSCs following treatment with
either stereospecific fucosyltransferase-VI (FTVI) or -VII
(FTVII) thereby creates the potent E-selectin ligand HCELL
on MSC surface. This surface glycan modification of MSCs by
exofucosylation has been previously shown to enhance tethering
and rolling on E-selectin-bearing endothelial cells, and yields
markedly increased in vivo murine and human MSC homing to
endothelial beds that express E-selectin such as bone marrow
and inflamed/injured tissues (Sackstein et al., 2008; Abdi et al.,
2015; Chou et al., 2017).
However, to date, apart from its augmented E-selectin
binding ability and the consequent improved in vivo migration
capacity to inflamed tissues, other phenotypic and functional
properties of MSCs after exofucosylation have not been tested.
To address this question, in the present work we performed
a direct comparison between unmodified murine AdMSCs
(UmAdMSCs, i.e., HCELL− mAdMSCs) and fucosylated
mAdMSCs (FucmAdMSCs, i.e., HCELL+ mAdMSCs), by
analyzing their cell morphology in culture, proliferation kinetics,
MSC immunophenotype, multipotent differentiation capacity,
expression of anti-inflammatory factors, secretory profiles,
anti-proliferative effect on mitogen-stimulated splenocytes,
wound healing effects and migration in vitro.
MATERIALS AND METHODS
Animals
C57BL/6 and β-actin-GFP transgenic C57BL/6-Tg(CAG-
EGFP) mice were purchased from Envigo (Huntingdon,
United Kingdom) and Jackson Laboratory (Bar Harbor, ME,
United States), respectively, and housed in a pathogen-free
environment at the animal supply facilities of the University of
Murcia and Foundation Health Research Institute-Fundación
Jiménez Díaz University Hospital.
Isolation of Adipose Murine
Mesenchymal Stromal Cell and Culture
Murine adipose tissue-derived mesenchymal stromal cells
(mAdMSCs) were isolated as reported previously (Yañez et al.,
2006). Briefly, adipose tissue was excised from the epididymal fat
pads, cut into small fragments, digested with 0.1% collagenase-
A (Roche Diagnostics, Basel, Switzerland) in serum-free DMEM
for 2 h at 37◦C, filtered through 40-µm nylon cell strainers
and cultured in MesenCult, a specific medium for the culture
of mouse MSCs (Stem Cell Technologies, Vancouver, Canada),
containing 1% L-glutamine (Gibco, Carlsbad, CA, United States),
100 U/ml penicillin, 100 µg/ml streptomycin (Gibco), 10%
serum, and growth factor supplement (Stem Cells Technologies;
complete medium). For experiments using IFNγ-stimulated
mAdMSCs, cells were incubated with 500 U/ml recombinant
murine IFNγ (R&D Systems, Minneapolis, MN, United States)
for 24 h at 37◦C.
Murine AdMSC Exofucosylation
Murine AdMSCs were resuspended at 2 × 107 cells/ml in
fucosyltransferase VII (FTVII) reaction buffer composed of
Hanks Balanced Salt Solution (HBSS; without Ca2+/Mg2+;
Lonza, Basel, Switzerland) containing 30 µg/ml FTVII (R&D
Systems), 20 mM HEPES (Sigma Aldrich, St. Louis, MO,
United States), 0.1% human serum albumin (Sigma Aldrich),
and 1 mM GDP-fucose (Sigma Aldrich), and treated for 60 min
at 37◦C (FucmAdMSCs). Negative controls were mAdMSCs
treated only with reaction buffer (w/o FTVII and GDP-fucose,
i.e., UmAdMSCs), mAdMSCs treated only with GDP-fucose
(w/o FTVII, i.e, GDP-fuc-mAdMSCs) and mAdMSCs treated
only with FTVII (w/o GDP-fucose, i.e., FTVII-mAdMSCs).
Concentrations of FTVII and GDP-fucose to achieve an optimal
efficiency of the exofucosylation protocol were determined
(Supplementary Figure 1).
Cell viability after fucosylation was assessed by trypan blue
exclusion and 7-AAD staining (usually≥ 95% live cells). Efficacy
of FTVII modification was evaluated by analysis of HECA452
antibody (BD Biosciences, San Jose, CA, United States) reactivity
and Ca2+−dependent mE-IgG chimera (R&D Systems) binding
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by flow cytometry. In some experiments, mAdMSCs after
fucosylation were digested with 0.1 U/ml Vibrio cholerae sialidase
(Roche Diagnostics) for 1 h at 37◦C to remove terminal sLex
decorations from cell surface glycoproteins, or with the broad-
spectrum peptidases bromelain (Sigma-Aldrich) and proteinase
K (Roche Diagnostics) to analyze whether E-selectin binding is
mediated by glycoproteins and/or glycolipids.
Western Blot Analysis
UmAdMSCs and FucmAdMSCs lysates were prepared with
lysis buffer containing 150 mM NaCl, 50 mM Tris–HCl (pH
7.4), 0.2% SDS, 2% NP-40 and protease inhibitor cocktail
(Thermo Scientific, Waltham, MA, United States). The cell
lysates were resolved on 4–20% precast polyacrylamide gels
(Bio-Rad, Hercules, CA, United States) and transferred onto
PVDF blotting membranes (GE Healthcare Life Science,
Barcelona, Spain). Then, membranes were blocked in TBS
containing 0.1% Tween-20 (Sigma Aldrich) and 5% skim milk
powder, incubated with mE-IgG chimera or anti-mouse CD44
primary antibody (clone IM7, Thermo Scientific) and then
with HRP-conjugated secondary antibodies. Finally, protein
bands were detected by chemiluminiscence using Lumi-Light
Western Blotting Substrate (Roche Diagnostics) according to the
manufacturer’s instructions.
Analysis of Secretome and ELISAs
Assays
For secretome analysis, UmAdMSCs or FucmAdMSCs were
plated at a cell density of 1 × 104 cells/cm2 and incubated
in complete medium at 37◦C. When cultures were 70–80%
confluent, cells were washed three times with PBS and re-
fed with serum-free media. After, conditioned media were
collected at different times of culture (from 0 h up to 72 h),
centrifuged at 200 g for 5 min, filtered through a 0.22-µm
syringe filter and stored at -80◦C until be analyzed. Finally,
analysis of the secretome of UmAdMSCs or FucmAdMSCs was
performed using the Bio-Plex Pro mouse cytokine, chemokine,
and growth factor magnetic bead-based assays (Bio-Rad) in a
Luminex system (Milliplex MAP, Merck, Darmstadt, Germany),
according to manufacturer instructions. Raw data of each analyte
concentration are shown in Supplementary Table 1. To evaluate
the ability of UmAdMSCs and FucmAdMSCs to secrete anti-
inflammatory molecules by ELISA assays, supernatants were
obtained culturing cells in the same conditions as above in
complete medium for 72 h at 37◦C. Levels of TGFβ, IL10,
PGE2, IDO1, galectin-1, HGF, and heme-oxygenase (HO) were
measured in the supernatants using specific mouse ELISA
kits purchased from Abcam (Cambridge, United Kingdom),
Cusabio Biotech (Houston, TX, United States), Diaclone
(Bionova Cientifica, Madrid, Spain), and Elabscience (Bethesda,
MD, United States).
Quantitative Real-Time PCR
Complementary DNA (cDNA) from UmAdMSCs and
FucmAdMSCs cultured in complete medium for 24 h was
synthesized from total mRNA, and gene expression was analyzed
by qRT-PCR using SYBR Green reagent (Takara, Kusatsu,
Japan) in an iQ5 real-time PCR detection system (Bio-Rad).
PCR thermal cycler conditions included a hold step of initial
denaturation at 95◦C for 10 s followed by two-step protocol
consisting of 40 cycles of denaturation at 95◦C for 5 s and
annealing/extension at 60◦C for 20 s. To control differences
on input mRNA amounts, the mouse Gapdh was used as
housekeeping gene to quantify and normalize the results. Fold-
change gene expression was assessed by the 2−1 1 Ct method.
The primer sequences used are listed in Supplementary Table 2.
Mitogen Stimulated Splenocyte
Proliferation Assays
Splenocytes were isolated by mechanical dissociation of the
spleen of C57BL/6 mice, followed by passage through 40-
µm cell strainers (BD Biosciences) and red blood cell lysis
with 0.8% ammonium chloride solution (Sigma Aldrich). Then,
splenocytes were resuspended in RPMI 1640 medium (Lonza)
containing 10% fetal bovine serum (FBS; Lonza), plated at
1 × 105 cells/well in 96-well plates and stimulated to proliferate
with 10 µg/ml concanavalin A (ConA; Sigma Aldrich). To
evaluate the immunosuppressive properties of mAdMSCs on
mitogen-induced splenocyte proliferation, five MSC:splenocyte
increasing ratios were used: 1:100, 1:50, 1:25, 1:10, and 1:1.
mAdMSC were previously irradiated at 15 Gy to avoid their
proliferation while preserving their viability. 3 days after co-
cultures, splenocyte proliferation was quantified using an ELISA
BrdU colorimetric kit (Roche Diagnostics), according to the
manufacturer’s instructions.
Proliferation Assays (MTT)
The proliferation of UmAdMSCs or FucmAdMSCs was evaluated
using the standard colorimetric MTT assays up to 7 days of cell
culture. In brief, cells were seeded at 1.5 × 103 cells/well in 96-
well plates and allowed to attach for 24 h. To determine cell
proliferation, wells were rinsed twice with PBS and incubated
with MTT reagent (5 mg/ml; Sigma Aldrich) resuspended in
DMEM w/o phenol red (Sigma Aldrich) for 4 h at 37◦C.
Then, 100 µl DMSO (Sigma Aldrich) was used to solubilize
the formazan. Finally, absorbance at 565 nm was measured.
Each condition was analyzed in quadruplicate. Alternatively,
proliferation kinetics of both types of mAdMSCs was analyzed
by calculating the cumulative population doubling (PD) level










represents the number of viable cells at seeding and Nt
the number of viable cells at harvest, as previously reported
(Christodoulou et al., 2013).
Mesenchymal Stromal Cell
Immunophenotyping
Murine AdMSCs were characterized by flow cytometry. Three
different pools of mAdMSCs (each of them isolated from 10
to 15 mice) and at different culture passages (from passage
2 up to passage 5) were analyzed the same day, and at least
5 × 104 events for all samples were recorded. Briefly, cells
were detached with TrypLE Express dissociation reagent (Gibco),
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washed, and resuspended in PBS (Gibco) containing 1% fetal
bovine serum (Lonza). Then, mAdMSCs were incubated with
fluorochrome-conjugated anti-mouse antibodies specific for the
surface markers CD73, CD90, CD105, CD44, PSGL-1, CD43,
CD29, Sca-1, CD106, CD166, CD34, CD45, CXCR4, c-Kit, CD80,
CD86 (all from BioLegend, San Diego, CA, United States) and
for the tetrasaccharide sialyl Lewis X/A (clone HECA452; BD
Biosciences), or their specific control isotype antibodies, for
30 min in the dark at 4◦C. Finally, cells were washed, resuspended
at 1 × 106 cells/ml and analyzed in a FACSCanto II flow
cytometer (BD Biosciences).
Multipotent Differentiation Assays
Murine AdMSCs were analyzed for their multipotent
differentiation capacity into the adipogenic, osteogenic,
and chondrogenic mesodermal lineages using the mouse
mesenchymal stem cell functional identification kit (R&D
Systems) following the manufacturer’s instructions. To determine
whether UmAdMSCs and FucmAdMSCs differentiate into
adipocytes, cells were cultured in MesenCult complete medium
with adipogenic supplement containing hydrocortisone,
isobutylmethylxanthine and indomethacin. After 14 days of
culture, cells were fixed with 4% paraformaldehyde in PBS and
stained with Oil Red O solution (Sigma Aldrich) to detect lipid-
laden vacuoles. For osteogenic differentiation, cells were cultured
in MesenCult complete medium with osteogenic supplement
containing ascorbate-phosphate, β-glycerophosphate and
recombinant human BMP-2. After 21 days of culture, cells
were fixed with 4% paraformaldehyde in PBS and stained
with Alizarin Red (Sigma Aldrich) to detect calcified matrix
culture depositions, or with SigmaFASTTM BCIP-NBT (Sigma
Aldrich) to analyze alkaline phosphatase activity, respectively.
For chondrogenic differentiation, mAdMSCs were cultured in
serum-free DMEM-F12 medium (Gibco) with chondrogenic
supplement containing dexamethasone, ascorbate-phosphate,
proline, pyruvate, recombinant human TGF-β3, and 1% ITS
supplement (insulin, transferrin, selenious acid, bovine serum
albumin, and linoleic acid; R&D Systems). In brief, 1 × 106
mAdMSCs were seeded in a 15-ml polypropylene tube and
centrifuged to obtain a pellet. The pellets were cultured in
chondrogenic medium or complete medium as negative
control, changing medium every 2–3 days. After 21 days of
culture, the pellets were fixed with 4% paraformaldehyde
in PBS, dehydrated, embedded in paraffin and 5-µm-thick
sections were cut. Chondrogenic differentiation was analyzed
by Alcian blue staining (Sigma Aldrich) to detect acidic
mucopolysaccharides.
These differentiation capacities were also demonstrated by
qPCR in order to detect the expression of specific adipogenic,
osteogenic, and chondrogenic genes in each mAdMSC sample.
Scratch-Culture and Transwell Migration
Assays
Scratch-culture migration assays were performed as previously
described (Collado-Gonzalez et al., 2017). In brief, UmAdMSCs,
GDP-fuc-mAdMSCs, FTVII-mAdMSCs, or FucmAdMSCs were
seeded into 12-well plates at a density of 1.5 × 105 cells/well and
cultured for 12 h to obtain confluent cell monolayers. Thereafter,
a scratch (wound) was performed in the confluent cell monolayer
with a sterile 10-µl pipette tip, and rinsed three times with
PBS to remove detached cells after wounding. The scratched
cell monolayers were maintained in complete medium at 37◦C.
To measure the extent of cell migration, images of the wound
area were captured at different times (i.e., 0, 24, and 48 h) with
an inverted phase-contrast microscope (Nikon, Tokyo, Japan).
ImageJ software (National Institutes of Health, Bethesda, MD,
United States) was used to measure the wound area reduction
after 24 h or 48 h related to the same wound area at 0 h.
Moreover, migration assays were carried out using the
transwell system (8-µm pore polycarbonate membrane, NUNC,
Roskilde, Denmark). The lower chamber contained MesenCult
medium containing 0.3% bovine serum albumin (Sigma Aldrich)
or 30% FBS as a positive control of cell migration. In
these experiments, mAdMSCs were previously irradiated to
inhibit their proliferation in presence of FBS and just analyze
differences in cell migration. Also, the chemotactic activity
of murine pro-inflammatory chemokines CCL5 (RANTES;
150 ng/ml), CCL11 (eotaxin; 100 ng/ml), CCL20 (MIP3α;
100 ng/ml), CCL22 (macrophage-derived chemokine, MDC;
100 ng/ml), and CXCL16 (50 ng/ml) on mAdMSCs migration
was evaluated. Concentrations of chemokines in the lower
chamber were chosen according to the optimal mAdMSC
migration index showed in previous experiments. All murine
recombinant chemokines was purchased from Novus Biologicals
(Littleton, CO, United States). Briefly, 1 × 105 UmAdMSCs,
GDP-fuc-mAdMSCs, FTVII-mAdMSCs, or FucmAdMSCs were
resuspended in MesenCult with 0.3% BSA and added to the
upper chamber, followed by incubation at 37◦C for 6 h to assess
chemokine activity or for 24 h to measure spontaneous cell
migration (BSA). Finally, extent of cell migration to the lower
chamber was quantified using an automated cell counter (Bio-
Rad TC20). Each condition was analyzed in triplicate. Data were
represented as percentages of migrated cells related to the control
(100% of migration).
Statistical Analysis
Data from the different experiments are represented as
mean± standard deviation (SD). Comparisons of results between
different experimental groups were analyzed using one-way
ANOVA and Tukey’s post-hoc comparison tests. P values < 0.05
were considered significant.
RESULTS
FTVII-Treatment of mAdMSCs Enforces
HCELL Expression
Flow cytometry analysis showed that unmodified mAdMSCs (i.e.,
UmAdMSCs) did not display any reactivity with the specific
anti-sLex monoclonal antibody (mAb) HECA452. In addition,
they did not bind to mouse E-selectin-IgG chimeric molecules
(mE-IgG; Figure 1A). Negative controls including mAdMSCs
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treated with GDP-fucose alone (i.e., GDP-fuc-mAdMSCs,
Figure 1B) and mAdMSCs treated with FTVII alone (i.e., FTVII-
mAdMSCs, Figure 1C) neither showed HECA452 nor mE-IgG
binding. However, exofucosylation enzymatic reaction provoked
a substantial up-regulation of sLex expression on mAdMSCs (i.e.,
FucmAdMSCs), evidenced by an intense staining with the mAb
HECA452 (Figure 1D, left), as well as a proportional Ca2+-
dependent mE-IgG binding (Figure 1D, middle). Digestion of
FucmAdMSCs with broad-spectrum peptidases [i.e., bromelain
(Brom) and proteinase K (Prot K)] significantly inhibits mE-
Ig binding, showing that glycoproteins are the main mE-IgG
ligands rather than sLex-decorated glycolipids (Figure 1D, right).
Additional western blot analysis of whole FucmAdMSC lysates
revealed that the main glycoprotein recognized by mE-IgG is the
∼100 kDa standard isoform of CD44 (i.e., CD44s; Figure 1E), as
previously reported for human and mouse bone marrow MSCs
(Sackstein et al., 2008; Abdi et al., 2015). Thus, exofucosylation of
mAdMSCs induced expression of HCELL.
In order to evaluate the variability on CD44 conversion
to HCELL glycoform, five different mAdMSC samples (i.e.,
mAdMSC pools isolated from 10 to 15 mice) were analyzed
after exofucosylation by flow cytometry, showing all of them
a comparable and homogeneous surface sLex expression
(Figure 1F, left). The maximum level of sLex expression on
mAdMSCs was achieved promptly after fucosylation, decreased
to ∼65% after 24 h and reached again basal levels (similar to
typical sLex expression on mAdMSCs) at 96 h post-treatment
(Figure 1F, right).
Comparative Analysis of the Produced
Secretome by UmAdMSCs and
FucmAdMSCs
To evaluate whether exofucosylation could alter mAdMSCs
secretome, we performed a comparative study of the secretome
released by both UmAdMSCs and FucmAdMSCs up to 72 h of
serum-free cultures, analyzing a set of cytokines and chemokines
involved in numerous immune pro- and anti-inflammatory
processes (Turner et al., 2014). We grouped these molecules
according to their recognized functional properties. Thus, we
evaluated the pro-inflammatory cytokines IFNγ, IL12 (p40 and
p70), IL17, IL1α, IL1β, GM-CSF, IL6, IL2, and TNFα; the anti-
inflammatory cytokines IL4 and IL10; chemokines and other
chemoattractant molecules such as KC (keratinocyte-derived
chemokine), MIP-1α, MIP-1α, MCP-1, RANTES and eotaxin;
and other cytokines or growth factors, such as G-CSF, IL3,
IL5, IL9, and IL13.
The production of the studied molecules followed the same
pattern in the cultures of both UmAdMSCs and FucmAdMSCs,
with a low production in the first hours of culture and gradually
increasing onward to reach maximum values in the last studied
stages (48 h and 72 h; Figures 2A–D).
For IL5 (12 h and 48 h), IL9 (4 h and 48 h), IL13 (12 h),
and G-CSF (4, 12, 48, and 72 h), production was significantly
higher in FucmAdMSCs compared to UmAdMSCs (Figure 2A).
Notably, at all time-points, all the studied chemokines and
chemoattractant molecules (eotaxin, KC, MCP-1, MIP1α, MIP1β,
and RANTES) showed higher values in FucmAdMSC cultures
than in UmAdMSC cultures (Figure 2B). Moreover, mostly at
48 h of culture, FucmAdMSCs also exhibited higher levels of pro-
inflammatory cytokines (i.e., IFNγ, IL12p40, and p70, IL1β, IL1α,
IL2, IL17, TNFα, IL6, and GM-CSF), although levels of these
molecules equalized to that of UmAdMSCs at 72 h (Figure 2C); in
contrast, production of anti-inflammatory cytokines, mainly IL4
(0, 4, and 24 h) but, also, IL10 (0 h and 24 h), was significantly
higher in UmAdMSCs (Figure 2D).
Comparative Evaluation of
Immunomodulatory Molecules in
FucmAdMSCs and UmAdMSCs With and
Without Stimulation by IFNγ
Apart from measurements of protein levels, we also performed
qPCR and ELISAs to evaluate the impact of exofucosylation
on gene expression of key immunomodulatory molecules
in AdMSCs cultured in complete medium. We evaluated
comparatively the produced transcripts in UmAdMSCs and
FucmAdMSCs under steady-state culture and following
treatment with IFNγ for 24 h to mimic conditions found in a
pro-inflammatory milieu. We observed that, except for Hgf, Ido1
and Ptgs2 (COX2), which showed no transcript level differences
between unstimulated UmAdMSCs and FucmAdMSCs, the
other studied molecules, including Hmox1 (heme-oxygenase),
Il10, Lgals1 (galectin-1), Ptgs1 (COX1), and Tgfb, showed
significantly higher RNA levels in unstimulated FucmAdMSCs
than in unstimulated UmAdMSCs or control mAdMSCs
(i.e., GDP-fuc-mAdMSCs and FTVII-mAdMSCs; Figure 3
and Supplementary Figure 2A). With IFNγ-stimulation
of UmAdMSCs or control mAdMSCs, Hmox1 and Ido1
levels increased, but there was no increase in the other
transcripts. In FucmAdMSCs treated with IFNγ, there were
increases in Hgf, Hmox1, and Tgfb transcripts, with markedly
increased levels of Ptgs2 and Ido1 (12-fold and 154-fold,
respectively; Figure 3). In addition, although Ido1 production
increased in IFNγ-stimulated UmAdMSCs, control mAdMSCs
and FucmAdMSCs, the increase in the latter was much
higher. However, Il10, Lgals1 and Ptgs1 transcripts did not
exhibit a significant increase in IFNγ-treated FucmAdMSCs
compared to unstimulated counterparts, suggesting that,
following exofucosylation, expression of these genes are not
further affected by IFNγ exposure. Nevertheless, when the
effects of IFNγ-stimulation were evaluated regarding protein
expression, TGFβ, IL10, PGE2, IDO1, Gal-1, HGF, and heme-
oxygenase (HO) values were significantly increased after
72 h of culture in FucmAdMSCs compared to UmAdMSCs
and control mAdMSCs (Figure 4A and Supplementary
Figure 2B). Importantly, this increased secretion of soluble
anti-inflammatory molecules was significantly abrogated by
digestion of sLeX-decorated HCELL molecules following
sialidase treatment of FucmAdMSCs (i.e., Sial FucmAdMSCs,
Figure 4A).
As the above described results indicated that the process
of fucosylation induces changes in properties of mAdMSCs,
we comparatively evaluated various other characteristics and
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FIGURE 1 | Exofucosylation induced E-selectin ligand expression in mAdMSCs. mAdMSCs were exofucosylated and analyzed for expression of sLex with HECA452
antibody and for Ca2+-dependent binding of the mE-IgG chimeric fusion protein, a reporter for E-selectin binding function. (A) Untreated mAdMSCs, (B,C) or only
treated with GDP-fucose or FTVII, respectively, did not stain with HECA452 nor bound to mE-IgG, whereas FTVII and GDP-fucose treatment induced a substantial
up-regulation of sLex expression (D, left) and a comparable binding of mE-IgG on mAdMSC surface (D, middle). Digestion of FucmAdMSCs with bromelain (Brom)
and proteinase K (Prot K) significantly inhibits Ca2+-dependent mE-Ig binding (D, right). Control isotype antibody staining or mE-IgG binding with control buffer (w/o
Ca2+) are represented as light gray histograms. (E) Western blot analysis of UmAdMSCs and FucmAdMSCs lysates to analyze mE-IgG reactivity (left). After,
membranes were reproved against murine CD44 as protein loading control (right). (F, left) Different pools of mAdMSCs (n = 5) were fucosylated (FucmAdMSCs) or
treated with buffer alone (UmAdMSCs) and analyzed for sLex expression with the HECA452 antibody by flow cytometry. Expression of sLex was significantly
up-regulated, ***p < 0.001. (F, right) Kinetics of sLex surface expression after FTVII-treatment of mAdMSCs. UmAdMSCs or FucmAdMSCs were analyzed for sLex
expression with the HECA452 antibody by flow cytometry up to 120 h post-fucosylation. MFI: Mean fluorescence intensity. Results are representative of three
independent experiments and were analyzed using one-way ANOVA.
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FIGURE 2 | Comparison of the secretome profile of UmAdMSCs and FucmAdMSC in conditioned media obtained along the time of culture. Pooled mAdMSCs
isolated from adipose tissue from several mice (n = 15) were treated with FTVII and the donor substrate GDP-fucose (FucmAdMSCs) or buffer alone (UmAdMSCs),
allowed to adhere, re-fed with serum-free media and cultured up to 72 h. At the indicated times, conditioned media samples from UmAdMSC or FucmAdMSC
cultures were collected, filtered and comparatively analyzed using the Bio-Plex Pro mouse cytokine, chemokine, and growth factor magnetic bead-based assays in a
Luminex system, according to the manufacturer’s instructions. The concentration of growth factors and other regulatory cytokines (A), chemokines (B),
pro-inflammatory cytokines (C), and anti-inflammatory cytokines (D) secreted by UmAdMSCs (red bars) or FucmAdMSCs (blue bars) were measured. Levels of each
analyte detected in the culture medium alone were used as blank. Data represent the mean ± SD from three independent experiments and were analyzed using
one-way ANOVA followed by Tukey’s post-hoc comparison tests. Levels of each analyte was significantly up-regulated in UmAdMSCs (red asterisks) or in
FucmAdMSCs (blue asterisks) at the indicated time points, *p < 0.05, **p < 0.01, or ***p < 0.001, respectively.
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FIGURE 3 | Analysis of the expression of immunomodulatory molecules in mAdMSCs by qPCR. Different pools of UmAdMSCs or FucmAdMSCs were allowed to
adhere and cultured in complete medium for 24 h. Then, cells were stimulated with IFNγ or left unstimulated (negative control) for additional 24 h. Then, expression
of hepatocyte growth factor (Hgf), heme-oxygenase 1 (Hmox1), indoleamine 2,3-dioxygenase (Ido1), interleukin-10 (Il10), galectin-1 (Lgals1), COX-1 (Ptgs1), COX-2
(Ptgs2), and transforming growth factor-β (Tgfb) were analyzed by qPCR. Mouse Gapdh was used as housekeeping gene to quantify and normalize the results.
Fold-change gene expression was assessed by the 2-11Ct method. Data represent the mean ± SD from three independent experiments and were analyzed using
one-way ANOVA followed by Tukey’s post-hoc comparison tests. Expression was significantly up-regulated in FucmAdMSCs compared to UmAdMSCs,
11p < 0.01, 111p < 0.001, or in IFNγ-stimulated mAdMSCs compared to unstimulated counterparts, *p < 0.05, **p < 0.01, and ***p < 0.001, respectively. ns: not
significant.
capabilities of UmAdMSCs and FucmAdMSCs in an attempt to




To assess whether HCELL expression functionally affects the
immunosuppressive properties of mAdMSCs, we analyzed
the capacity of UmAdMSCs and FucmAdMSCs, previously
treated or not with IFNγ for 24 h, to inhibit mitogen-
stimulated splenocyte proliferation. We observed that
concanavalin A (ConA)-stimulated splenocyte proliferation
was significantly decreased when increasing ratios of
mAdMSCs (from 1:100 to 1:10 MSC:splenocyte) were
added to the cultures (Figure 4B). However, IFNγ-treated
FucmAdMSCs displayed a significant suppression of
splenocyte proliferation from 1:50 MSC:splenocyte ratio
compared to their untreated counterparts, whereas IFNγ-
treated UmAdMSCs or IFNγ-treated Sial FucmAdMSCs
required a higher ratio MSC:splenocyte (i.e., 1:10) to show
a significant immunosuppressive effect on ConA-splenocyte
proliferation (Figure 4B).
To further investigate the relevance of mAdMSC secretome
on their observed immunosuppressive effect, we performed
additional mitogenic assays using conditioned media from
MSC:splenocyte co-cultures (1:25 ratio). Supernatants obtained
from co-cultures containing IFNγ-stimulated FucmAdMSCs
showed a significant inhibition of mitogen-induced splenocyte
proliferation compared to that observed with UmAdMSCs or Sial
FucmAdMSC conditioned media, and to an extent comparable to
that found in the continuous presence of mAdMSCs (Figure 4C).
Morphology and Cell Proliferation of
UmAdMSCs and FucmAdMSCs
In order to analyze whether fucosylation could affect MSC
morphology, UmAdMSCs and FucmAdMSCs were cultured up
to 72 h. Both cell types displayed similar plastic adherence, a
spindle-shape and a fibroblast-like morphology, typical of MSCs
(Figure 5A). In addition, proliferation assays were carried out
with the two cell types using the standard colorimetric MTT
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FIGURE 4 | (A) Analysis of immunomodulatory molecule secretion in mAdMSCs by ELISA. Different pools of UmAdMSCs, FucmAdMSCs, or sialidase-treated
FucmAdMSCs (Sial FucmAdMSCs) were allowed to adhere and cultured in complete medium for 24 h. After, cells were stimulated or not (negative control) with IFNγ
for 24 h and cultured for additional 48 h. As control, other group of FucmAdMSCs cells were cultured for 96 h (FucmAdMSCs 96 h) before stimulation with IFNγ for
24 h. Then, levels of secreted transforming growth factor-β (TGFβ), interleukin-10 (IL10), prostaglandin E2 (PGE2), indoleamine 2,3-dioxygenase 1 (IDO1), galectin-1
(Gal-1), hepatocyte growth factor (HGF), and heme-oxygenase 1 (HO) were analyzed by ELISA. Data represent the mean ± SD from three independent experiments
and were analyzed using one-way ANOVA followed by Tukey’s post-hoc comparison tests. Levels of each molecule was significantly up-regulated in FucmAdMSCs
(Continued)
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FIGURE 4 | Continued
compared to UmAdMSCs, 1p < 0.05, 11p < 0.01, or in IFNγ-stimulated mAdMSCs compared to their unstimulated counterparts, *p < 0.05, **p < 0.01,
***p < 0.001, or in IFNγ-stimulated FucmAdMSCs compared to INFγ-stimulated UmAdMSCs or compared to IFNγ-stimulated Sial FucmAdMSCs, +p < 0.05,
++p < 0.01, +++p < 0.001, or in IFNγ-stimulated FucmAdMSCs 96 h compared to IFNγ-stimulated UmAdMSCs, #p < 0.05, ##p < 0.01, and ###p < 0.001,
respectively. ns: not significant. (B) Concanavalin A-stimulated splenocytes were co-cultured with different ratios of UmAdMSCs, FucmAdMSCs, Sial FucmAdMSCs,
and FucmAdMSCs 96 h, previously treated or not with IFNγ for 24 h. After 3 days of co-cultures, splenocyte proliferation was determined by BrdU incorporation.
Data represent the mean ± SD from three independent experiments and were analyzed using one-way ANOVA followed by Tukey’s post-hoc comparison tests.
Splenocyte proliferation in presence of IFNγ-stimulated mAdMSCs was significantly inhibited compared to their unstimulated counterparts at each specific
MSC:splenocyte ratio, *p < 0.05, ***p < 0,001, respectively. Spl, splenocyte, ConA, concanavalin A. (C) Additional mitogenic experiments were performed with
ConA-stimulated splenocytes in presence of conditioned media obtained from MSC:splenocyte co-cultures at 1:25 ratio. After 3 days of culture, splenocyte
proliferation was measured by BrdU incorporation. Data represent the mean ± SD from three independent experiments and were analyzed using one-way ANOVA
followed by Tukey’s post-hoc comparison tests. Splenocyte proliferation in presence of IFNγ-stimulated mAdMSC:splenocyte conditioned media was significantly
inhibited compared to proliferation levels obtained with conditioned media from unstimulated MSC:splenocyte co-cultures, ***p < 0,001.
assay and cumulative PD calculation up to 7 days of culture. Both
UmAdMSCs and FucmAdMSC exhibited significantly similar
exponential cell growth curves and cumulative PD (p > 0.05;
Figure 5B).
FTVII-Treatment of mAdMSCs Does Not
Alter Cell Immunophenotype or
Multilineage Differentiation Efficiency
As determined by flow cytometry, mAdMSCs expressed typical
MSC surface markers such as CD73, CD90, CD105, CD44, CD29
(β1 integrin), Sca-1, CD106 (VCAM-1), and CD166 (ALCAM-
1), together with low or no expression of the hematopoietic
markers CD34, CD45, CXCR4, c-Kit, CD80 and CD86, or
other E-selectin ligands such as PSGL-1 or CD43 (Figure 6A).
To further evaluate whether exofucosylation could modify the
immunophenotypic profile of mAdMSCs, we analyzed the
expression of the positive MSC markers up to 72 h post-
treatment and in different mAdMSC culture passages (from
passage 2 up to passage 5). Despite a slight up- or down-
regulation of some markers, presumably due to differences in cell
confluence along the time of culture, FucmAdMSCs displayed no
significant different percentage of positive expression and mean
fluorescence intensity values (MFI) for these markers compared
to UmAdMSCs (p > 0.05; Supplementary Table 3).
Moreover, we evaluated whether FTVII-treatment could affect
the multilineage differentiation potential of mAdMSCs. For
this purpose, UmAdMSCs, and FucmAdMSCs were cultured in
either adipogenic, osteogenic, or chondrogenic differentiation
media. After specific qualitative staining, FucmAdMSCs showed
no apparent visual differences in the formation of cytoplasmic
lipid-laden vacuoles (adipocytes; Figure 6B, top left), in the
levels of matrix calcium deposits or alkaline phosphatase activity
(osteoblasts; Figure 6B, top right and bottom right, respectively),
and neither in expression of acidic mucopolysaccharides
(chondroblasts; Figure 6B, bottom left). However, qPCR
analyses revealed a significantly different expression of several
adipocyte –, i.e., adiponectin (Adipoq) and PPARγ2 (Pparg2)-,
chondroblast –, i.e., SOX9 (Sox9) and epiphycan (Epyc)- and
osteoblast –, i.e., alkaline phosphatase (Alp1), osteocalcin (Bglap)
and collagen type I (Col1a1)-lineage-specific markers between
UmAdMSCs and FucmAdMSCs (Figure 6C). These results
suggest that although FucmAdMSCs are able to differentiate
efficiently to adipocyte, osteoblast and chondroblast cell lineages,
exofucosylation could affect the transition or length of the
different stages during MSC multipotent differentiation.
Comparative Evaluation of the Migratory
Capacities of UmAdMSCs and
FucmAdMSCs
To evaluate migratory capacity, scratch was performed in
confluent cultures of UmAdMSCs, GDP-fuc-mAdMSCs, FTVII-
mAdMSCs, or FucmAdMSCs, and the scratched area was
measured after 24 h and 48 h of culture (Figure 7A). At
both times, the scratched area was significantly smaller in
FucmAdMSCs than in UmAdMSCs or control mAdMSCs
(Figure 7A). FucmAdMSCs also exhibited significantly higher
spontaneous migratory capabilities than UmAdMSCs or control
mAdMSCs in transwell assays (BSA, Figure 7B, top left),
and in response to several pro-inflammatory chemokines [i.e.,
CCL20 (MIP3α), CXCL16 and CCL5 (RANTES)] (Figure 3B),
confirming what has been reported using other approaches
(Kocher et al., 2001; Sackstein et al., 2008; Abdi et al., 2015;
Dykstra et al., 2016).
DISCUSSION
Mesenchymal stromal cells currently represent the most
promising cell type for cell therapy largely due to their anti-
inflammatory and immunomodulatory properties (Caplan, 2007;
Chamberlain et al., 2007). However, there are many unresolved
questions regarding the therapeutic applications of these cells.
To date, four E-selectin ligands have been identified:
cutaneous lymphocyte antigen (CLA, sialofucosylated PSGL-1
glycoform), E-selectin ligand-1 (ESL-1), CD43E (sialofucosylated
CD43 glycoform), and hematopoietic cell E-selectin/L-selectin
ligand (HCELL, sialofucosylated CD44 glycoform), whose
expression is restricted to leukocytes and hematopoietic stem
cells (Hidalgo et al., 2007; Merzaban et al., 2011; Silva et al., 2017).
However, MSCs do not express any sLex-decorated E-selectin
ligand, which results in the lack of specific migration of these
cells to inflamed tissues, since E-selectin, heavily expressed in the
endothelial cells on the sites of inflammation after stimulation
by pro-inflammatory cytokines (Schweitzer et al., 1996; Jung
et al., 1997; Yao et al., 1999; Chong et al., 2004), is necessary
for cell transmigration. In this respect, Sackstein and colleagues
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FIGURE 5 | Analysis of the cell morphology and proliferation of UmAdMSCs and FucmAdMSCs. (A) UmAdMSCs and FucmAdMSCs were cultured up to 72 h to
analyze their typical MSC morphology. Phase-contrast and fluorescence microscopy images at higher magnification of GFP-expressing mAdMSCs are shown. Scale
bar: 100 µm. (B) UmAdMSCs and FucmAdMSCs were cultured up to 168 h to analyze their cell proliferation rates using the standard colorimetric MTT assay (B, left)
or calculating their cumulative population doubling (PD; B, right) using the formula specified in the Materials and Methods section.
demonstrated that both extracellular (Sackstein et al., 2008;
Abdi et al., 2015; Pachón-Peña et al., 2016), and intracellular
fucosylation of CD44, resulted in increased MSC migration to
bone or to damaged tissues (Abdi et al., 2015; Dykstra et al., 2016).
Apart from differences in E-selectin binding, no other
differences have been reported to date between FTVII-modified
and unmodified MSCs. In agreement with our current results,
Chou et al. found no changes in differentiation between
exofucosylated and native bone marrow-derived MSCs, nor
differences in cell proliferative rate after ten passages of cultures
(Chou et al., 2017). However, our present results indicate that
there are important differences between the pattern of soluble
molecules secretion of UmAdMSCs and FucmAdMSCs, a feature
not described previously. Other studies reported differences
between MSC secretome largely related with the source of cells
(Hsiao et al., 2012; Hsieh et al., 2013; Amable et al., 2014; Du et al.,
2016), isolation methods, culture conditions and detection assays
as well as due to species-specific variations (Chen et al., 2008; Park
et al., 2009; Rodriguez et al., 2015; Hirose et al., 2018). Recently,
it has been described that other type of cells such as memory T
regulatory cells (Tregs), the vast majority of which heavily express
sLex and exhibit strong transendothelial migration ability, but not
naïve Tregs which show lower levels of sialofucosylated E-selectin
ligands (Donnelly et al., 2018), produce differentially IL17 and
IFNγ (Koenen et al., 2008; Booth et al., 2010).
After serum withdrawal (experimental conditions shown
in Figure 2), FucmAdMSCs produce significantly more pro-
inflammatory cytokines (i.e., IFNγ, IL12p40/p70, IL1β, IL2,
IL6, GM-CSF, IL17, and TNFα) and other regulatory cytokines
and growth factors (i.e., G-CSF, IL5, IL9, and IL13) than
UmAdMSC, a fact that has been related with activated MSCs
(Rodriguez et al., 2015). It is important to remark that it has
been previously addressed that MSCs are sensitive to serum
or nutrient deprivation, a situation they may encounter in an
ischemic microenvironment (Nuschke et al., 2016). Survival
mechanisms up-regulated in MSCs in response to starvation
include, among others, activation of autophagy pathways, and
some phenotypic changes such as an increased differentiation
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FIGURE 6 | Fucosylation of mAdMSCs does not affect MSC immunophenotype or multilineage differentiation properties. (A) mAdMSCs expressed typical MSC
surface markers such as CD73, CD90, CD105, CD44, CD29, Sca-1, CD106, and CD166, and displayed a negligible or negative expression of CD34, CD45,
CXCR4, c-Kit, CD80 and CD86, or other E-selectin ligands such as PSGL-1 or CD43. Control isotype antibodies staining are represented as light gray histograms.
Representative results from n = 3 independent experiments are shown. (B) UmAdMSCs or FucmAdMSCs were cultured in specific media to evaluate their in vitro
differentiation capacity into the adipogenic, osteogenic and chondrogenic lineages. Adipogenic differentiation was evaluated by staining of cytoplasmic lipid-laden
vacuoles with Oil Red O (adipocytes; B, top left), whereas osteogenic commitment was analyzed by staining of calcium deposits with Alizarin Red (B, top right) or
alkaline phosphatase activity with BCIP-NBT (B, bottom right). Chondrogenic differentiation was evaluated by staining of acidic mucopolysaccharides with Alcian
blue (B, bottom left). Images shown are representative of three independent differentiation assays. Scale bar: 200 µm. (C) Expression of adiponectin (Adipoq),
PPARγ2 (Pparg2), SOX9 (Sox9), epiphycan (Epyc), alkaline phosphatase (Alp1), osteocalcin (Bglap), and collagen type I (α1 chain; Col1a1) were analyzed by qPCR.
Mouse Gapdh was used as housekeeping gene to quantify and normalize the results. Fold-change gene expression was assessed by the 2-11Ct method. Data
represent the mean ± SD from three independent experiments and were analyzed using one-way ANOVA followed by Tukey’s post-hoc comparison tests.
Expression was significantly up-regulated or down-regulated in FucmAdMSCs compared to UmAdMSCs, *p < 0.05, **p < 0.01, respectively.
capacity (Pantovic et al., 2013; Nuschke et al., 2014). However,
to date it has not been described in the literature how lack of
nutrients may affect the secretory profile of MSCs. Other authors
have described a similar activation pattern after exposing MSCs
to different pro-inflammatory stimuli such as IFNγ, TNFα, IL-1β,
lipopolysaccharide or hypoxia, a process which depends on the
nuclear factor-kappa B (NF-κB) signaling pathway (Crisostomo
et al., 2008). On the other hand, increased production of some of
these pro-inflammatory cytokines by extravasated FucmAdMSCs
could favor, in a paracrine fashion, the migratory capacity
of other circulating FucmAdMSCs through its local effect on
endothelium. It is well known that TNFα and IL1, IL12, IL-6, IL-
13, IFNγ, or IL17A, alone or in synergy with TNFα, differentially
up-regulate the expression of several adhesion molecules on
microvascular endothelial cells at sites of tissue injury or
inflammation, in particular, E-selectin, VCAM-1, and ICAM-1
(Pober et al., 1986a,b; Bevilacqua et al., 1987; Dustin and Springer,
1988; Bochner et al., 1995; Vestweber and Blanks, 1999; Stocker
et al., 2000; Strasly et al., 2001; Chiu et al., 2007; Sackstein, 2009;
Griffin et al., 2012). Also, G-CSF induces endothelial expression
of E-selectin and ICAM-1 through activation of p38MAPK
(Fuste et al., 2004). On the other hand, some pro-inflammatory
cytokines produced by MSCs have indirectly immunosuppressive
properties. For instance, IL2 promotes the development of
CD4+CD25+FoxP3+ Tregs (Malek et al., 2000; Malek, 2003;
Burchill et al., 2007), that represent an immunomodulatory T cell
specialized subset able to neutralize the development of immune-
mediated damage and to promote repair and regeneration of
affected target-organs in systemic immune diseases (Sakaguchi
et al., 1995; Gatza et al., 2008). Also, IL9 has been described
to enhance the immunosuppressive function of Tregs (Elyaman
et al., 2009; Eller et al., 2011), and IL13 inhibits pro-inflammatory
cytokine production and shares anti-inflammatory properties
with IL4 (de Waal Malefyt et al., 1993; Minty et al., 1993).
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FIGURE 7 | Exofucosylation increases the migratory capacity of mAdMSCs. (A) Migration of UmAdMSCs, GDP-fuc-mAdMSCs, FTVII-mAdMSCs, and
FucmAdMSCs were analyzed by wound-healing assays. After obtaining confluent monolayers of both types of cells, a scratch was performed. Subsequently, images
of the scratched area were captured after 24 h or 48 h of wounding. Then, the wound areas at the indicated times were calculated in relative to the total wound area
at 0 h of the same wound spot. Representative images of initial scratch (0 h) or after 24 h are shown. Each condition was analyzed in triplicate. Wound area in
FucmAdMSC cultures was significantly lower, *p < 0.05, **p < 0.01, respectively. Scale bar: 100 µm. (B) Migration assays were carried out using a transwell
system. UmAdMSCs, GDP-fuc-mAdMSCs, FTVII-mAdMSCs, and FucmAdMSCs were allowed to migrate toward MesenCult medium containing 30% FBS (positive
control of cell migration) or 0.3% BSA (spontaneous migration) for 24 h at 37◦C. Also, mAdMSC-induced migration in response to the indicated pro-inflammatory
chemokines was analyzed after incubation for 6 h at 37◦C. Extent of cell migration to the lower chamber was quantified. FucmAdMSC migration was significantly
increased, *p < 0.01, **p < 0.01, respectively, according to one-way ANOVA followed by Tukey’s post-hoc comparison tests. Each condition was analyzed in
triplicate. Data were expressed as mean percentages ± SD of migrated cells related to the positive control (FBS) or input (100% of migration).
Previous studies reported that MSCs isolated from different
sources secrete numerous chemokines, i.e., SDF-1/CXCL12,
MCP-1/CCL2, MCP-2/CCL8, MCP-3/CCL7, eotaxin/CCL11,
GCP-2/CXCL6, KC/CXCL1, IP10/CXCL10, and others (Ma et al.,
2014; Rodriguez et al., 2015). In the present work, we show that
FucmAdMSCs secrete increased levels of several chemokines (i.e.,
eotaxin, KC, MCP-1, MIP1α, MIP1β, and RANTES) compared
to their unmodified counterparts. Ren et al. (2008) reported
that after stimulation with various pro-inflammatory cytokines,
MSCs increase their ability to secrete high levels of chemokines
that attract neighboring inflammatory immune cells (i.e., T cells)
into proximity with MSCs, suppressing T cell responses by
production of nitric oxide. On the other hand, we have found
in standard conditions of culture (i.e., in presence of nutrients
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and growth factors) that expression of the anti-inflammatory
cytokine IL10 and other immunosuppressive factors, such as
PTGS1 (COX1), HO, and TGFβ were higher in FucmAdMSCs
than in UmAdMSCs. Remarkably, after IFNγ-stimulation, the
expression of these molecules at protein level, particularly that
of IDO1, increased enormously in FucmAdMSCs, as previously
reported (Chon et al., 1996; Ren et al., 2009), and retained
the ability to secrete significant higher levels of other anti-
inflammatory molecules (i.e., TGFβ, IL10, PGE2, Gal-1, HGF,
and HO) that mediate their observed higher anti-proliferative
effects in a pro-inflammatory milieu even after they have already
lost HCELL expression (i.e., FucmAdMSCs 96 h; Figures 4A–
C). Thus, and in agreement with results of Ren et al. (2008),
our findings also suggest that a higher production of chemokines
and anti-inflammatory molecules acquired by mAdMSCs after
their FTVII-treatment could favor a local negative feedback
loop, suppressing the inflammatory immune response in the
vicinity of MSCs.
Our results also indicate that exofucosylated mAdMSCs show
a higher spontaneous migration capability and in response
to different inflammatory chemokines than their unmodified
counterparts. Given the well-known role of chemokines in the
recruitment and homing of immune cells to tissues (Moser
and Loetscher, 2001), our findings suggests that FucmAdMSCs,
apart from their enhanced tethering and rolling contacts
on E-selectin-bearing endothelial cells, could possess some
additional advantages in their chemokine-mediated homing to
inflamed or injured tissues after systemic administration.
First question emerging from our study is how the absence
or presence of nutrients in a concrete microenvironment
could affect tissue-resident mAdMSC phenotype and function
regarding secretion of different soluble mediators. In presence
of nutrients and growth factors, which are in vitro provided by
the serum of the culture medium, mAdMSCs exhibited an anti-
inflammatory phenotype, mainly in FucmAdMSCs stimulated
with IFNγ, whilst starvation induced a switch from an anti-
inflammatory FucmAdMSC phenotype to another one that
mainly secreted pro-inflammatory cytokines, growth factors
and chemokines. Accordingly, the nutritional deficiency or
abundance that a certain tissue presents depending on factors
such as anatomical location or blood supply, can greatly affect the
mAdMSCs functional properties and therefore their subsequent
immunomodulatory response.
Secondly, it has not been previously addressed how enzymatic
exofucosylation could result in this distinct, specific behavior
and how it can also affect the immunomodulatory properties
of FucmAdMSCs. In this respect, it is possible that CD44 and
its sialofucosylated form HCELL could establish cis-interactions
resulting in different cellular behavior of FucmAdMSCs
compared to UmAdMSCs, interacting with different ligands
or establish interactions of different intensity and/or time
length. Although we have not studied these mechanisms in
detail in this work, we believe that this difference [i.e., an
additional fucose residue added after exofucosylation in α(1,3)
of N-acetylglucosamine of terminal tetrasaccharyde sLex]
(Sackstein, 2009) could be sufficient to alter the molecule affinity
resulting in different signaling and activation. In this respect,
CD44v expressed on tumor cells but not CD44s expressed
on MSCs can form molecular clusters (Sleeman et al., 1996).
Recently, we demonstrated that an altered adhesion affected
importantly the behavior of bone marrow human MSCs (Alfaro
and Zapata, 2018). Taking all our results together, the changes
in the cellular behavior induced by exofucosylation, ultimately
results in a functional polarization of the MSCs toward an
inhibitory, scarce pro-inflammatory phenotype.
In summary, these results provide new perspectives on the
functional features and mechanisms of action of FucmAdMSCs
that could have important therapeutic consequences,
highlighting the specific secretome observed in FucmAdMSCs
and its possible in vivo relevance in a variety of preclinical studies.
CONCLUSION
This study represents an in-depth phenotypical and functional
direct comparison between native mAdMSCs and mAdMSCs
modified by FTVII-exofucosylation, an enzymatic method
to specifically induce the transient surface expression of the
E-selectin ligand HCELL. Compared to their unmodified
counterparts, fucosylated mAdMSCs display a consistent
increased, although transient, expression of HCELL, an
augmented production of growth factors, chemokines and
other chemoattractants and regulatory molecules, a higher
expression/secretion of several anti-inflammatory molecules and
remarkably an increased migratory and immunosuppressive
properties, even after they have lost HCELL expression.
Collectively, our findings suggest that fucosylation of MSCs
is not only a suitable strategy to favor the recruitment of
systemically infused-MSCs to the damaged tissues but also this
surface glycan engineering converts MSCs into a more potent
immunomodulatory/anti-inflammatory cell-based product for
the treatment of a variety of autoimmune, inflammatory and
degenerative diseases.
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